GSTM1 and anemia (phenotype): Among studies administering BMZ alone, a higher Hb at baseline was associated with a larger impact on moderate anaemia (P= 0.02), but there was no evidence of a differential impact when iron supplementation was co-administered in both arms of the trial (P= 0.69 and P= 0.63).